Shuying FENG | Functional Genomics | Best Researcher Award

Posted on by Computational Biologists

Prof. Shuying FENG | Functional Genomics | Best Researcher Award

Director at Henan University of Chinese Medicine, China.

Dr. Shuying Feng is a Professor, PhD, and Postdoctoral Supervisor at Henan University of Chinese Medicine, where he leads several key research centers focused on functional and special medical foods. A nationally recognized expert in traditional Chinese medicine, his work integrates nanotechnology, probiotic fermentation, gene editing, and the medical application of natural products. Dr. Shuying Feng has published over 100 papers (90+ SCI-indexed), holds 21 national invention patents, and has directed numerous national and provincial projects. He is also a distinguished academic leader, mentor, and recipient of multiple scientific and technological awards.

🎓 Academic Background :

Dr. Shuying Feng is a highly accomplished Professor and Doctoral/Postdoctoral Supervisor at Henan University of Chinese Medicine. Holding a PhD and serving as a leading scholar in his field, Dr. Shuying Feng is also a member of the Communist Party of China. He currently leads several prominent research institutions, including the Henan Engineering Research Center for Special Medical Foods of Traditional Chinese Medicine, and serves as Executive Director of the Institute of Functional Foods and Medicine-Food Homologous Research. His academic leadership has significantly influenced the advancement of traditional Chinese medicine and functional food research across Henan Province and beyond.

Profile:

Professional Experience:

Dr. Shuying Feng has extensive professional experience as a professor, researcher, and academic leader in the field of traditional Chinese medicine and functional foods. He currently serves as Director of multiple research centers, including the Henan Engineering Research Center for Special Medical Foods, and holds executive roles at key provincial and municipal laboratories. Over his career, he has led more than 30 national, provincial, and industry-funded research projects, secured significant research funding, and guided numerous graduate and postdoctoral researchers. His work has resulted in over 100 publications, 21 national patents, and wide-ranging contributions to both academic and industrial advancements in medical food innovation.

🔬 Research Interests:

Dr. Shuying Feng’s research spans several pioneering fields within biomedical science and traditional medicine. His primary areas of interest include the development of functional and special medical foods, the nanoization and probiotic fermentation enhancement of traditional Chinese medicine, gene editing and its applications in microalgae, and the medical applications of bee products. His multidisciplinary approach bridges ancient medicinal wisdom with cutting-edge biotechnology, driving innovation in both health and food sciences.

🏅 Honors & Recognition:

Dr. Shuying Feng has been recognized with numerous accolades, including the title of Distinguished Professor of Henan Province, High-Level Talent (Category C), Academic and Technical Leader by the Henan Department of Education, and Outstanding Young Backbone Teacher in Higher Education. At the city level, he has been named an Excellent Scientific and Technological Talent. These honors underscore his contributions to both academic excellence and public service in the field of medical science.

🏛️ Leadership & Roles:

Beyond his research and teaching, Dr. Feng holds influential roles in academic societies. He is Vice Chairman of the Tumor Cell Professional Committee of the Henan Cell Biology Society and a council member of both the Fermentation Research Committee under the World Federation of Chinese Medicine Societies and the Henan Biochemistry and Molecular Biology Society. These leadership positions highlight his commitment to collaborative scientific advancement and community engagement.

Publications:

  • Meng, Y., Si, Y., Guo, T., Sun, K., & Feng, S. (2025). Ethoxychelerythrine as a potential therapeutic strategy targets PI3K/AKT/mTOR induced mitochondrial apoptosis in the treatment of colorectal cancer. Scientific Reports.
    🔹 Citations: 1

  • Ji, C., Li, S., Hu, C., Yin, S., & Feng, S. (2024). Traditional Chinese medicine as a promising choice for future control of PEDV. (Journal name not specified).
    🔹 Citations: 0

  • Zhang, B., Wang, Q., Zhang, Y., Wang, B., & Feng, S. (2024). Treatment of insomnia with traditional Chinese medicine presents a promising prospect. (Journal name not specified).
    🔹 Citations: 0

  • Yang, Y., Li, S., Shi, W., Lu, B., & Feng, S. (2024). Pterostilbene suppresses the growth of esophageal squamous cell carcinoma by inhibiting glycolysis and PKM2/STAT3/c-MYC signaling pathway. International Immunopharmacology.
    🔹 Citations: 1

  • Wei, W., Guo, T., Fan, W., Ma, W., & Feng, S. (2024). Integrative analysis of metabolome and transcriptome provides new insights into functional components of Lilii Bulbus. Chinese Herbal Medicines.
    🔹 Citations: 5

Akhilesh Mishra | Single Cell Genomics | Best Researcher Award

Posted on by Computational Biologists

Assist.Prof.Dr.Akhilesh  Mishra |  Single Cell Genomics |  Best Researcher Award 

Assistant Professor at  National Institute of Technology Rourkela,  India.

Dr. Akhilesh Mishra is an accomplished Assistant Professor in the Department of Life Science at the National Institute of Technology (NIT) Rourkela, Odisha, India. His academic path began with a Bachelor’s degree in Botany and Chemistry, followed by dual Master’s degrees—one in Bioinformatics and the other in Botany. He earned his Ph.D. from the Supercomputing Facility for Bioinformatics and Computational Biology (SCFBio) at IIT Delhi, where he decoded the physicochemical and structural language of DNA. Dr. Mishra further honed his expertise through postdoctoral fellowships at UT Southwestern Medical Center and St. Jude Children’s Research Hospital, USA.

🎓 Educational Background:

Dr. Akhilesh Mishra’s academic journey reflects a strong foundation in both life sciences and computational biology. He began his higher education with a Bachelor’s degree in Botany and Chemistry, where he developed an early interest in biological systems and their underlying mechanisms. Driven by a passion for understanding complex biological data, he pursued dual postgraduate degrees—a Master’s in Bioinformatics and a Master’s in Botany—equipping himself with a rare blend of computational skills and deep biological insight. His pursuit of research excellence led him to earn a Ph.D. from the Supercomputing Facility for Bioinformatics and Computational Biology (SCFBio) at IIT Delhi, one of India’s premier institutions. During his doctoral studies, he focused on the physicochemical and structural features of DNA, laying the groundwork for his future contributions to computational oncology. Further enriching his academic experience, Dr. Mishra completed postdoctoral fellowships at UT Southwestern Medical Center and St. Jude Children’s Research Hospital in the United States, where he engaged in cutting-edge cancer genomics and bioinformatics research.

Profile:

Research Focus:

Dr. Mishra leads the Computational Oncology Lab at NIT Rourkela, where he applies cutting-edge multi-omics and computational tools to decode the complexities of cancer biology. His vision is rooted in leveraging interdisciplinary approaches—integrating genomics, transcriptomics, epigenetics, and spatial data—to unravel molecular drivers of renal cell carcinoma (RCC), pediatric brain tumors, and antimicrobial resistance.

Publications:

  • Molecular dynamics simulation-based trinucleotide and tetranucleotide level structural and energy characterization of the functional units of genomic DNA. Physical Chemistry Chemical Physics, 2023.

  • HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans. Clinical Cancer Research, 2022.

  • Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma. European Urology, 2022.

  • Intron exon boundary junctions in human genome have in-built unique structural and energetic signals. Nucleic Acids Research, 2021.

  • A novel method SEProm for prokaryotic promoter prediction based on DNA structure and energetics. Bioinformatics, 2020.

  • PRIMER SETS, BIOMARKERS, KIT AND APPLICATIONS THEREOF. Indian Institute of Technology Delhi, Patent, 2020.

  • Prion protein transcription is auto-regulated through dynamic interactions with G-quadruplex motifs in its own promoter. Biochimica et Biophysica Acta (BBA) – Gene Regulatory Mechanisms, 2020.

  • ChemGenome2.1: An ab initio gene prediction software. In Gene Prediction, Book Chapter, 2019.

  • Toward a Universal Structural and Energetic Model for Prokaryotic Promoters. Biophysical Journal, 2018.

  • A computational protocol for the discovery of lead molecules targeting DNA unique to pathogens. Methods, 2017.

  • Physico-chemical fingerprinting of RNA genes. Nucleic Acids Research, 2017.

  • Onco-Regulon: an integrated database and software suite for site specific targeting of transcription factors of cancer genes. Database, 2016.

  • A Novel Anticlustering Filtering Algorithm for the Prediction of Genes as a Drug Target. American Journal of Biomedical Engineering, 2012.